|
2011
|
P 005091
|
Inhibitor of deubiquitinase USP7 and USP47 |
€95.00 |
|
1906
|
P 22077
|
Inhibitor of deubiquitinase USP7 and USP47 |
€95.00 |
|
1936
|
P 505-15
|
Inhibitor of spleen tyrosine kinase (Syk) |
€105.00 |
|
1958
|
P2Y14 Antagonist Prodrug 7j hydrochloride
|
Prodrug of P2Y14 receptor antagonist |
€125.00 |
|
2602
|
P7C3
|
Proneurogenic and neuroprotective compound that activates NAMPT |
€105.00 |
|
1743
|
PAC 1
|
Procaspase activating compound 1 |
€80.00 |
|
1594
|
Pagoclone, (+)-
|
GABAA-α2 and GABAA-α3 agonist |
€135.00 |
|
2052
|
Palbociclib isethionate
|
Orally active cyclin-dependent kinase (CDK4/6) inhibitor |
€125.00 |
|
1211
|
Palmitoylethanolamide
|
Endocannabinoid; GPR55 agonist |
€75.00 |
|
1718
|
Palomid 529
|
mTOR inhibitor |
€90.00 |
|
3101
|
Palonosetron hydrochloride
|
Highly potent, selective and orally active 5-HT3 antagonist |
€150.00 |
|
3161
|
Pantoprazole sodium
|
Proton pump inhibitor (PPI) |
Recently added
|
€50.00 |
|
1482
|
Parogrelil
|
PDE3 inhibitor |
€125.00 |
|
1452
|
Paroxetine hydrochloride
|
SSRI |
€75.00 |
|
3152
|
PAWI-2
|
Inhibitor which targets both Wnt signaling and ATM/p53 |
Recently added
|
€120.00 |